News
Prof. Dr. René Thyrian re-elected as board member of the German Alzheimer Society
The delegates' meeting of the German Alzheimer Society took place in Kassel on November 16th. The board was…
Highly Cited: Several DZNE Scientists Among the World’s Most Impactful Researchers
Researchers whose studies are frequently cited in scientific journals are viewed as influential, as being…
Executive Board
Prof. Dr. Dr. Pierluigi Nicotera
Prof. Dr. Dr. Pierluigi Nicotera, a renowned scientist and leading international expert in the field of neuronal cell death,…
European Medicines Agency recommends refusal of marketing authorization of novel Alzheimer’s drug
The European Medicines Agency (EMA) has recommended the refusal of the marketing…
European Medicines Agency recommends approval of novel Alzheimer's drug
The European Medicines Agency (EMA) has recommended the drug “Lecanemab” (brand name: Leqembi) for treatment of…
Completed projects of the working group
Agewell.de
A multicenter cluster-randomized controlled multicomponent intervention study to prevent cognitive decline in elderly primary care…
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
